$CBDY
Target Group Inc.

2022 Q4 Form 10-Q Financial Statement

#000141057822002980 Filed on November 07, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $0.00
YoY Change
Gross Profit $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $340.3K $340.7K $313.7K
YoY Change 204.07% 8.58% 12.87%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $211.9K $220.4K $241.0K
YoY Change -11.86% -8.55% 1113.44%
% of Gross Profit
Operating Expenses $326.3K $278.5K $427.4K
YoY Change 56.82% -34.84% 40.25%
Operating Profit -$427.4K
YoY Change 40.25%
Interest Expense -$245.1K $269.1K $266.1K
YoY Change -283.88% 1.13% 49.54%
% of Operating Profit
Other Income/Expense, Net $64.34K -$50.89K $2.624M
YoY Change 344.34% -101.94% -172.66%
Pretax Income -$3.922M -$286.1K $2.197M
YoY Change 6367.38% -113.03% -156.09%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$3.922M -$286.1K $2.197M
YoY Change 6367.38% -113.03% -156.09%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share -$0.01 $0.00 $3.562K
COMMON SHARES
Basic Shares Outstanding 617.0M 617.0M 616.7M
Diluted Shares Outstanding 617.0M 616.7M

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $223.8K $197.7K $45.18K
YoY Change 97.95% 337.61% -93.82%
Cash & Equivalents $232.3K $206.1K $54.21K
Short-Term Investments
Other Short-Term Assets $680.4K $560.6K $338.2K
YoY Change 97.5% 65.78% 3.42%
Inventory $0.00 $99.00K $99.00K
Prepaid Expenses $41.71K $41.22K $44.35K
Receivables $2.068K $2.068K $2.068K
Other Receivables $3.690K $3.650K $15.18K
Total Short-Term Assets $910.0K $863.0K $499.6K
YoY Change 55.76% 72.75% -60.93%
LONG-TERM ASSETS
Property, Plant & Equipment $5.554M $5.699M $7.074M
YoY Change -18.82% -19.45% -10.2%
Goodwill $263.1K $3.406M $3.664M
YoY Change -92.85% -7.05%
Intangibles
YoY Change
Long-Term Investments $775.6K $569.2K $1.616M
YoY Change -58.53% -64.77% 898.49%
Other Assets
YoY Change
Total Long-Term Assets $6.656M $9.740M $12.44M
YoY Change -46.66% -21.72% -22.11%
TOTAL ASSETS
Total Short-Term Assets $910.0K $863.0K $499.6K
Total Long-Term Assets $6.656M $9.740M $12.44M
Total Assets $7.566M $10.60M $12.94M
YoY Change -42.08% -18.07% -24.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.120M $4.450M $1.318M
YoY Change 326.57% 237.56% -48.57%
Accrued Expenses $1.792M $1.466M $96.17K
YoY Change -11.6% 1423.98% -92.88%
Deferred Revenue $0.00
YoY Change
Short-Term Debt $990.00 $990.00 $85.87K
YoY Change 0.0% -98.85% 2265.56%
Long-Term Debt Due $1.737M $1.839M $926.3K
YoY Change 188.7% 98.53%
Total Short-Term Liabilities $6.927M $6.380M $3.614M
YoY Change 71.33% 76.52% -13.91%
LONG-TERM LIABILITIES
Long-Term Debt $5.958M $5.765M $7.394M
YoY Change -23.22% -22.02%
Other Long-Term Liabilities $1.320M $1.332M $2.292M
YoY Change -14.84% -41.9% -79.76%
Total Long-Term Liabilities $7.198M $7.005M $11.43M
YoY Change -35.57% -38.72% 0.94%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.927M $6.380M $3.614M
Total Long-Term Liabilities $7.198M $7.005M $11.43M
Total Liabilities $14.13M $13.39M $15.05M
YoY Change -7.16% -11.04% -3.08%
SHAREHOLDERS EQUITY
Retained Earnings -$30.78M -$26.86M -$26.20M
YoY Change 17.21% 2.51%
Common Stock $61.70K $61.70K $61.67K
YoY Change 0.0% 0.06%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$6.560M -$2.783M -$2.105M
YoY Change
Total Liabilities & Shareholders Equity $7.566M $10.60M $12.94M
YoY Change -42.08% -18.07% -24.98%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$3.922M -$286.1K $2.197M
YoY Change 6367.38% -113.03% -156.09%
Depreciation, Depletion And Amortization $211.9K $220.4K $241.0K
YoY Change -11.86% -8.55% 1113.44%
Cash From Operating Activities $55.38K $129.0K -$236.2K
YoY Change -90.89% -154.59% -17.12%
INVESTING ACTIVITIES
Capital Expenditures -$10.00 $0.00 $20.00
YoY Change -100.0% -100.05%
Acquisitions
YoY Change
Other Investing Activities -$225.1K $50.15K -$105.6K
YoY Change -53.73% -147.48% -68.64%
Cash From Investing Activities -$225.1K $50.15K -$105.6K
YoY Change -53.35% -147.49% -72.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 193.1K -82.63K 305.1K
YoY Change -565.14% -127.08% -79.2%
NET CHANGE
Cash From Operating Activities 55.38K 129.0K -236.2K
Cash From Investing Activities -225.1K 50.15K -105.6K
Cash From Financing Activities 193.1K -82.63K 305.1K
Net Change In Cash 23.39K 96.49K -36.75K
YoY Change -72.15% -362.56% -104.57%
FREE CASH FLOW
Cash From Operating Activities $55.38K $129.0K -$236.2K
Capital Expenditures -$10.00 $0.00 $20.00
Free Cash Flow $55.39K $129.0K -$236.3K
YoY Change -154.59% -3.06%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.0005
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.0036
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.0010
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.0001
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
617025999
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
616668856
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
617025999
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
588351180
CY2021Q4 us-gaap Assets Current
AssetsCurrent
584222
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000
dei Entity Central Index Key
EntityCentralIndexKey
0001586554
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Trading Symbol
TradingSymbol
CBDY
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
617025999
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
617025999
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55066
dei Entity Registrant Name
EntityRegistrantName
TARGET GROUP INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-3621499
dei Entity Address Address Line1
EntityAddressAddressLine1
20 Hempstead Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Hamilton
dei Entity Address City Or Town
EntityAddressCityOrTown
Ontario
dei Entity Address Country
EntityAddressCountry
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
L8W 2E7
dei City Area Code
CityAreaCode
1 905
dei Local Phone Number
LocalPhoneNumber
541-3833
dei Security12g Title
Security12gTitle
Common Stock, Par Value $0.0001
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
617025999
CY2022Q3 us-gaap Cash
Cash
197705
CY2021Q4 us-gaap Cash
Cash
113079
CY2022Q3 us-gaap Restricted Cash
RestrictedCash
8390
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
9072
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2068
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2068
CY2022Q3 us-gaap Inventory Net
InventoryNet
99000
CY2021Q4 us-gaap Inventory Net
InventoryNet
99000
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
41222
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
44567
CY2021Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
21637
CY2022Q3 us-gaap Due From Joint Ventures Current
DueFromJointVenturesCurrent
510985
CY2021Q4 us-gaap Due From Joint Ventures Current
DueFromJointVenturesCurrent
290855
CY2022Q3 us-gaap Other Receivables
OtherReceivables
3648
CY2021Q4 us-gaap Other Receivables
OtherReceivables
3944
CY2022Q3 us-gaap Assets Current
AssetsCurrent
863018
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5698651
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6841770
CY2022Q3 us-gaap Equity Method Investments
EquityMethodInvestments
569194
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
1870123
CY2022Q3 us-gaap Goodwill
Goodwill
3405882
CY2021Q4 us-gaap Goodwill
Goodwill
3682236
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
66176
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
84618
CY2022Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
9739903
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
12478747
CY2022Q3 us-gaap Assets
Assets
10602921
CY2021Q4 us-gaap Assets
Assets
13062969
CY2022Q3 us-gaap Bank Overdrafts
BankOverdrafts
506
CY2021Q4 us-gaap Bank Overdrafts
BankOverdrafts
506
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1941134
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2885909
CY2021Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
10000
CY2022Q3 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
10979
CY2022Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
4309399
CY2021Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
1037104
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
106990
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
101356
CY2022Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
480
CY2021Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
480
CY2022Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
10678
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
7902
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
6380166
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4043257
CY2022Q3 us-gaap Accounts Payable Related Parties Noncurrent
AccountsPayableRelatedPartiesNoncurrent
5673712
CY2021Q4 us-gaap Accounts Payable Related Parties Noncurrent
AccountsPayableRelatedPartiesNoncurrent
9621696
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1331212
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1528033
CY2022Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
468
CY2021Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
22095
CY2022Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
7005392
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
11171824
CY2022Q3 us-gaap Liabilities
Liabilities
13385558
CY2021Q4 us-gaap Liabilities
Liabilities
15215081
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
100
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
100
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
61703
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
61703
CY2022Q3 cbdy Shares To Be Issued Total
SharesToBeIssuedTotal
175109
CY2021Q4 cbdy Shares To Be Issued Total
SharesToBeIssuedTotal
174722
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24985697
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24985697
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-26861862
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-26263614
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1143384
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1110720
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-2782637
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-2152112
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10602921
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13062969
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
246
CY2021Q3 us-gaap Professional Fees
ProfessionalFees
6453
us-gaap Professional Fees
ProfessionalFees
18939
us-gaap Professional Fees
ProfessionalFees
15068
CY2022Q3 us-gaap Management Fee Expense
ManagementFeeExpense
19399
CY2021Q3 us-gaap Management Fee Expense
ManagementFeeExpense
72562
us-gaap Management Fee Expense
ManagementFeeExpense
102915
us-gaap Management Fee Expense
ManagementFeeExpense
226359
CY2021Q3 cbdy Salary And Wage Nonofficer
SalaryAndWageNonofficer
2051
cbdy Salary And Wage Nonofficer
SalaryAndWageNonofficer
-9775
cbdy Salary And Wage Nonofficer
SalaryAndWageNonofficer
8811
CY2022Q3 us-gaap Legal Fees
LegalFees
41253
CY2021Q3 us-gaap Legal Fees
LegalFees
72065
us-gaap Legal Fees
LegalFees
213844
us-gaap Legal Fees
LegalFees
187862
CY2022Q3 us-gaap Depreciation
Depreciation
220390
CY2021Q3 us-gaap Depreciation
Depreciation
240983
us-gaap Depreciation
Depreciation
673349
us-gaap Depreciation
Depreciation
731126
CY2022Q3 cbdy Operating Lease Income Expense
OperatingLeaseIncomeExpense
81976
CY2021Q3 cbdy Operating Lease Income Expense
OperatingLeaseIncomeExpense
-30318
cbdy Operating Lease Income Expense
OperatingLeaseIncomeExpense
115881
cbdy Operating Lease Income Expense
OperatingLeaseIncomeExpense
-653
CY2022Q3 cbdy General And Administrative Income Expense
GeneralAndAdministrativeIncomeExpense
-79195
CY2021Q3 cbdy General And Administrative Income Expense
GeneralAndAdministrativeIncomeExpense
-7084
cbdy General And Administrative Income Expense
GeneralAndAdministrativeIncomeExpense
-10249
cbdy General And Administrative Income Expense
GeneralAndAdministrativeIncomeExpense
10643
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
278507
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
427414
us-gaap Operating Expenses
OperatingExpenses
913190
us-gaap Operating Expenses
OperatingExpenses
1141614
CY2022Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
2040
CY2021Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
2842168
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
18852
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
2204772
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
26360
CY2022Q3 us-gaap Interest Expense
InterestExpense
269106
CY2021Q3 us-gaap Interest Expense
InterestExpense
266098
us-gaap Interest Expense
InterestExpense
830167
us-gaap Interest Expense
InterestExpense
718784
CY2022Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
130870
CY2021Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
67015
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
172863
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-24910
CY2022Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
49346
CY2021Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
4694
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
747122
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
14021
CY2022Q3 cbdy Allowance Recovery For Sales Tax Recoverable
AllowanceRecoveryForSalesTaxRecoverable
-1756
CY2021Q3 cbdy Allowance Recovery For Sales Tax Recoverable
AllowanceRecoveryForSalesTaxRecoverable
23223
cbdy Allowance Recovery For Sales Tax Recoverable
AllowanceRecoveryForSalesTaxRecoverable
503
cbdy Allowance Recovery For Sales Tax Recoverable
AllowanceRecoveryForSalesTaxRecoverable
21725
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
93819
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-33458
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
244867
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-7971
CY2022Q3 cbdy Debt Issuance Costs
DebtIssuanceCosts
12855
CY2021Q3 cbdy Debt Issuance Costs
DebtIssuanceCosts
13318
cbdy Debt Issuance Costs
DebtIssuanceCosts
39098
cbdy Debt Issuance Costs
DebtIssuanceCosts
40080
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-50890
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2624226
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
271694
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1475133
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-286149
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2196812
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-598248
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
333519
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-286149
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
2196812
us-gaap Net Income Loss
NetIncomeLoss
-598248
us-gaap Net Income Loss
NetIncomeLoss
333519
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-15319
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-64772
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-32664
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
51048
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-301468
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2132040
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-630912
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
384567
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.0005
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.0036
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.0010
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.0001
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
617025999
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
616668856
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
617025999
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
588351180
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-2481289
CY2022Q3 cbdy Shares To Be Issued As Compensation To Intellectual Property Rights Value
SharesToBeIssuedAsCompensationToIntellectualPropertyRightsValue
120
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-286149
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-15319
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-2782637
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-4237182
CY2021Q3 cbdy Shares To Be Issued As Compensation To Intellectual Property Rights Value
SharesToBeIssuedAsCompensationToIntellectualPropertyRightsValue
280
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
2196812
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-64772
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-2104862
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-2152112
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
387
us-gaap Net Income Loss
NetIncomeLoss
-598248
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-32664
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-2782637
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-3521219
cbdy Shares To Be Issued As Compensation To Intellectual Property Rights Value
SharesToBeIssuedAsCompensationToIntellectualPropertyRightsValue
1107
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2648
cbdy Adjustments To Additional Paid In Capital Extinguishment Of Derivative Liability Upon Conversion Of Notes
AdjustmentsToAdditionalPaidInCapitalExtinguishmentOfDerivativeLiabilityUponConversionOfNotes
-228
cbdy Stock Held During Period Value New Issues
StockHeldDuringPeriodValueNewIssues
-1027807
us-gaap Net Income Loss
NetIncomeLoss
333519
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
51048
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-2104862
us-gaap Profit Loss
ProfitLoss
-598248
us-gaap Profit Loss
ProfitLoss
333519
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
18852
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
2204772
cbdy Net Gain Loss On Settlement Of Liability
NetGainLossOnSettlementOfLiability
26360
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
408
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
4258
cbdy Recovery Of Sales Tax Recoverable
RecoveryOfSalesTaxRecoverable
503
cbdy Recovery Of Sales Tax Recoverable
RecoveryOfSalesTaxRecoverable
21725
us-gaap Depreciation And Amortization
DepreciationAndAmortization
673349
us-gaap Depreciation And Amortization
DepreciationAndAmortization
731126
us-gaap Operating Lease Expense
OperatingLeaseExpense
198254
us-gaap Operating Lease Expense
OperatingLeaseExpense
204433
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
244867
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-7971
cbdy Debt Issuance Costs
DebtIssuanceCosts
39098
cbdy Debt Issuance Costs
DebtIssuanceCosts
40080
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-2400
cbdy Increase Decrease In Sales Tax Recoverable
IncreaseDecreaseInSalesTaxRecoverable
33629
cbdy Increase Decrease In Sales Tax Recoverable
IncreaseDecreaseInSalesTaxRecoverable
87068
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-75943
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-901898
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
512553
cbdy Change In Operating Lease Liability Net
ChangeInOperatingLeaseLiabilityNet
250575
cbdy Change In Operating Lease Liability Net
ChangeInOperatingLeaseLiabilityNet
254329
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1070205
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-507835
cbdy Payments For Proceeds From Property Plant And Equipment
PaymentsForProceedsFromPropertyPlantAndEquipment
318
cbdy Payments For Proceeds From Property Plant And Equipment
PaymentsForProceedsFromPropertyPlantAndEquipment
3923
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-1240429
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
919574
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1240111
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-923497
us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
85373
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
77980
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
239820
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
138393
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
1027807
cbdy Payment For Settlement Payable
PaymentForSettlementPayable
10000
cbdy Payment For Settlement Payable
PaymentForSettlementPayable
60000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-70413
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1293000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
99493
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-138332
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-15549
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10908
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
122151
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
181629
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
206095
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
54205
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
2648
us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
120
us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
504
us-gaap Interest Paid Net
InterestPaidNet
2102799
us-gaap Interest Paid Net
InterestPaidNet
473034
CY2022Q3 us-gaap Area Of Land
AreaOfLand
44000
CY2020 cbdy Class Of Warrant Or Right Warrants Exercised During Period
ClassOfWarrantOrRightWarrantsExercisedDuringPeriod
0
cbdy Warrants Purchase
WarrantsPurchase
7211213
CY2021 cbdy Class Of Warrant Or Right Warrants Exercised During Period
ClassOfWarrantOrRightWarrantsExercisedDuringPeriod
0
CY2022Q3 cbdy Settlement Liabilities Current And Noncurrent
SettlementLiabilitiesCurrentAndNoncurrent
0
CY2021Q4 cbdy Settlement Liabilities Current And Noncurrent
SettlementLiabilitiesCurrentAndNoncurrent
10000
CY2022Q3 cbdy Working Capital Deficit
WorkingCapitalDeficit
5517148
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-26861862
CY2022Q3 us-gaap Inventory Net
InventoryNet
99000
CY2021Q4 us-gaap Inventory Net
InventoryNet
99000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">The preparation of the unaudited condensed consolidated interim financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated interim financial statements and the reported amounts of revenues and expenses during the reporting periods. Estimates may include those pertaining to accruals. Actual results could materially differ from those estimates.</span></p>
CY2022Q3 cbdy Gross Operating Leases Rent And Utilities Expenses
GrossOperatingLeasesRentAndUtilitiesExpenses
135584
CY2021Q3 cbdy Gross Operating Leases Rent And Utilities Expenses
GrossOperatingLeasesRentAndUtilitiesExpenses
97154
cbdy Gross Operating Leases Rent And Utilities Expenses
GrossOperatingLeasesRentAndUtilitiesExpenses
387474
cbdy Gross Operating Leases Rent And Utilities Expenses
GrossOperatingLeasesRentAndUtilitiesExpenses
327505
CY2022Q3 cbdy Recoverable Expenses From Jv Co Related To Rent And Utilities
RecoverableExpensesFromJvCoRelatedToRentAndUtilities
282775
CY2022Q3 cbdy Inventory Pledged As Collateral
InventoryPledgedAsCollateral
99000
CY2021Q4 cbdy Inventory Pledged As Collateral
InventoryPledgedAsCollateral
99000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1438202
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
106990
cbdy Revenue From Investments In Joint Venture
RevenueFromInvestmentsInJointVenture
3177105
cbdy Revenue From Investments In Joint Venture
RevenueFromInvestmentsInJointVenture
1469900
CY2021Q3 cbdy Recoverable Expenses From Jv Co Related To Rent And Utilities
RecoverableExpensesFromJvCoRelatedToRentAndUtilities
133760
cbdy Recoverable Expenses From Jv Co Related To Rent And Utilities
RecoverableExpensesFromJvCoRelatedToRentAndUtilities
701609
cbdy Recoverable Expenses From Jv Co Related To Rent And Utilities
RecoverableExpensesFromJvCoRelatedToRentAndUtilities
531285
CY2022Q3 cbdy Operating Lease Expenses Total
OperatingLeaseExpensesTotal
-81976
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
80821
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
322846
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
318874
CY2021Q4 cbdy Allowance On Value Added Tax Recoverable
AllowanceOnValueAddedTaxRecoverable
509
CY2017Q3 us-gaap Area Of Land
AreaOfLand
44000
CY2019Q2 us-gaap Area Of Land
AreaOfLand
44000
cbdy Depreciation Expense Recorded
DepreciationExpenseRecorded
672503
cbdy Depreciation Expense Recorded
DepreciationExpenseRecorded
864866
CY2021Q3 cbdy Operating Lease Expenses Total
OperatingLeaseExpensesTotal
30318
cbdy Operating Lease Expenses Total
OperatingLeaseExpensesTotal
-115881
cbdy Operating Lease Expenses Total
OperatingLeaseExpensesTotal
653
us-gaap Interest Expense Debt
InterestExpenseDebt
27
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8139958
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2441307
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5698651
CY2020Q2 cbdy Loans To Joint Venture Term Of Debt
LoansToJointVentureTermOfDebt
P5Y
cbdy Number Of Customers To Whom Revenue Was Sold
NumberOfCustomersToWhomRevenueWasSold
5
cbdy Number Of Customers To Whom Revenue Was Sold
NumberOfCustomersToWhomRevenueWasSold
6
CY2022Q3 cbdy Sale Of By Products
SaleOfByProducts
50769
cbdy Sale Of By Products
SaleOfByProducts
146740
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
322063
CY2022Q3 cbdy Assets Balance Of Joint Venture
AssetsBalanceOfJointVenture
9427983
CY2022Q3 cbdy Assets Balance Of Joint Venture
AssetsBalanceOfJointVenture
6878656
CY2021Q4 cbdy Assets Balance Of Joint Venture
AssetsBalanceOfJointVenture
4830446
CY2021Q4 cbdy Assets Balance Of Joint Venture
AssetsBalanceOfJointVenture
3810256
CY2022Q3 cbdy Liabilities Balance Of Joint Venture
LiabilitiesBalanceOfJointVenture
9990047
CY2022Q3 cbdy Liabilities Balance Of Joint Venture
LiabilitiesBalanceOfJointVenture
7288739
CY2021Q4 cbdy Liabilities Balance Of Joint Venture
LiabilitiesBalanceOfJointVenture
6020535
CY2021Q4 cbdy Liabilities Balance Of Joint Venture
LiabilitiesBalanceOfJointVenture
4748998
CY2022Q3 cbdy Equity Of Joint Venture
EquityOfJointVenture
-562065
CY2022Q3 cbdy Equity Of Joint Venture
EquityOfJointVenture
-410082
CY2021Q4 cbdy Equity Of Joint Venture
EquityOfJointVenture
-1190089
CY2021Q4 cbdy Equity Of Joint Venture
EquityOfJointVenture
-938742
CY2021 cbdy Class Of Warrant Or Right Warrants Exercised During Period
ClassOfWarrantOrRightWarrantsExercisedDuringPeriod
0
CY2020 cbdy Class Of Warrant Or Right Warrants Exercised During Period
ClassOfWarrantOrRightWarrantsExercisedDuringPeriod
0
CY2022Q3 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
881174
CY2022Q3 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
1130000
CY2022Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
138392
CY2022Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
177472
CY2022Q3 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
742782
CY2022Q3 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
952528
CY2022Q3 cbdy Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
1433613
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2478217
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1040015
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
353293
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
1976772
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
2806338
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
2467874
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
7604277
CY2022Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
1839075
CY2022Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5765202
CY2020Q3 cbdy Debt Issuance Costs
DebtIssuanceCosts
251518
CY2022Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
140609
CY2022Q3 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
48955
CY2022Q3 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
91654
CY2022Q3 cbdy Accrued Interest Converted Into Principal
AccruedInterestConvertedIntoPrincipal
72960
CY2022Q3 cbdy Accrued Interest Converted Into Principal
AccruedInterestConvertedIntoPrincipal
100000
us-gaap Interest Expense Debt
InterestExpenseDebt
99
CY2022Q2 cbdy Business Acquisition Fair Value Of Equity Interest Issued Or Issuable
BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable
306
CY2022Q1 cbdy Business Acquisition Fair Value Of Equity Interest Issued Or Issuable
BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable
430
CY2021Q4 cbdy Share Based Compensation Share Based Payments Forfeiture Rate
ShareBasedCompensationShareBasedPaymentsForfeitureRate
0
CY2021Q3 cbdy Share Based Compensation Share Based Payments Forfeiture Rate
ShareBasedCompensationShareBasedPaymentsForfeitureRate
0
CY2021Q2 cbdy Share Based Compensation Share Based Payments Forfeiture Rate
ShareBasedCompensationShareBasedPaymentsForfeitureRate
0
CY2022Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
2636380
CY2022Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
1923502
CY2022Q3 us-gaap Line Of Credit
LineOfCredit
2636380
CY2022Q3 us-gaap Line Of Credit
LineOfCredit
1923502
us-gaap Line Of Credit Facility Periodic Payment Interest
LineOfCreditFacilityPeriodicPaymentInterest
467128
us-gaap Line Of Credit Facility Periodic Payment Interest
LineOfCreditFacilityPeriodicPaymentInterest
640252
CY2022Q3 cbdy Line Of Credit Facility Accrued Interest
LineOfCreditFacilityAccruedInterest
261797
CY2022Q3 cbdy Line Of Credit Facility Accrued Interest
LineOfCreditFacilityAccruedInterest
358823
cbdy Number Of Operating Lease Facilities
NumberOfOperatingLeaseFacilities
2
CY2022Q3 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.16
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1331212
CY2022Q3 cbdy Gross Operating Lease Expense
GrossOperatingLeaseExpense
65215
CY2021Q3 cbdy Gross Operating Lease Expense
GrossOperatingLeaseExpense
66924
cbdy Gross Operating Lease Expense
GrossOperatingLeaseExpense
198254
cbdy Gross Operating Lease Expense
GrossOperatingLeaseExpense
204433
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
7902
cbdy Effect Of Conversion Of Convertible Notes
EffectOfConversionOfConvertibleNotes
0
cbdy Derivative Liability Changes Due To Issuance
DerivativeLiabilityChangesDueToIssuance
0
cbdy Change In Fair Value Of Derivative Liability
ChangeInFairValueOfDerivativeLiability
2776
CY2022Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
10678
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
850000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
850000000
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
617025999
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
617025999
us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
100
cbdy Schedule Of Shares To Be Issued
ScheduleOfSharesToBeIssued
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Shares to be issued include the following:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:29.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:47.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:29.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:47.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Description</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:29.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;width:47.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">80,000 shares of common stock to be issued as compensation to advisers and consultants. These were recorded at fair value of $52,000, based on the market price of the Company’s stock on the date of issue.</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:29.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:47.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:29.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Services</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 115,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 73,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:47.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">35,000 to be issued as settlement of the amount due for website development services amounting to $247,306. The fair value of the shares on the date of settlement was $21,000, resulting in a gain on settlement amounting to $226,306 during the year ended December 31, 2017.</p></td></tr><tr><td style="vertical-align:bottom;width:29.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Private placements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 346,296</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18,787</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;width:47.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Consideration for private placements with the fair value based on cash proceeds received. Proper allocation between common stock and additional paid-in capital of the amount received will be completed in the period when the shares are issued.</p></td></tr><tr><td style="vertical-align:bottom;width:29.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Settlement of loans of CannaKorp</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 930,240</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 80,838</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;width:47.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Refer to Note 14 for details.</p></td></tr><tr><td style="vertical-align:bottom;width:29.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Agreement with Serious Seeds</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 171,864</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,484</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;width:47.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">As consideration for intellectual property rights granted by Smit. The fair value is based on the market price of the Company’s stock on the date of issue as per the agreement.</p></td></tr><tr><td style="vertical-align:bottom;width:29.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,563,400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 175,109</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:47.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p>
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
115000
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
73000
CY2022Q3 cbdy Share Based Compensation Share Based Payments Forfeiture Rate
ShareBasedCompensationShareBasedPaymentsForfeitureRate
0
CY2022Q2 cbdy Share Based Compensation Share Based Payments Forfeiture Rate
ShareBasedCompensationShareBasedPaymentsForfeitureRate
0
CY2022Q1 cbdy Share Based Compensation Share Based Payments Forfeiture Rate
ShareBasedCompensationShareBasedPaymentsForfeitureRate
0
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.300
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.300
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.250
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
2.79
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
2.99
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
3.06
CY2022Q3 cbdy Fair Value Assumptions Term
FairValueAssumptionsTerm
P2Y
CY2022Q2 cbdy Fair Value Assumptions Term
FairValueAssumptionsTerm
P2Y
CY2022Q1 cbdy Fair Value Assumptions Term
FairValueAssumptionsTerm
P2Y
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q3 cbdy Business Acquisition Fair Value Of Equity Interest Issued Or Issuable
BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable
288
CY2021Q1 cbdy Share Based Compensation Share Based Payments Forfeiture Rate
ShareBasedCompensationShareBasedPaymentsForfeitureRate
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.250
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.250
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
3
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
3.02
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
3.04
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
3.06
CY2021Q4 cbdy Fair Value Assumptions Term
FairValueAssumptionsTerm
P2Y
CY2021Q3 cbdy Fair Value Assumptions Term
FairValueAssumptionsTerm
P2Y
CY2021Q2 cbdy Fair Value Assumptions Term
FairValueAssumptionsTerm
P2Y
CY2021Q1 cbdy Fair Value Assumptions Term
FairValueAssumptionsTerm
P2Y
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q4 cbdy Business Acquisition Fair Value Of Equity Interest Issued Or Issuable
BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable
524
CY2021Q3 cbdy Business Acquisition Fair Value Of Equity Interest Issued Or Issuable
BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable
807
CY2021Q2 cbdy Business Acquisition Fair Value Of Equity Interest Issued Or Issuable
BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable
114211
CY2021Q1 cbdy Business Acquisition Fair Value Of Equity Interest Issued Or Issuable
BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable
2152191
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
53950001
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
350178339
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
22095
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
1045
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
-22673
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
467
us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
1359103
us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
1862805
CY2022Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
10720

Files In Submission

Name View Source Status
R18.htm Edgar Link pending
0001410578-22-002980-index-headers.html Edgar Link pending
0001410578-22-002980-index.html Edgar Link pending
0001410578-22-002980.txt Edgar Link pending
0001410578-22-002980-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tmb-20220930.xsd Edgar Link pending
tmb-20220930x10q.htm Edgar Link pending
tmb-20220930xex10d29.htm Edgar Link pending
tmb-20220930xex10d30.htm Edgar Link pending
tmb-20220930xex10d31.htm Edgar Link pending
tmb-20220930xex31d1.htm Edgar Link pending
tmb-20220930xex31d2.htm Edgar Link pending
tmb-20220930xex32d1.htm Edgar Link pending
tmb-20220930_cal.xml Edgar Link unprocessable
tmb-20220930_lab.xml Edgar Link unprocessable
tmb-20220930_pre.xml Edgar Link unprocessable
tmb-20220930_def.xml Edgar Link unprocessable
tmb-20220930x10q_htm.xml Edgar Link completed